Rob Brainin was named CEO of Champions Oncology, a provider of oncology-focused contract research organization services specializing in preclinical and clinical specialty testing. He has been a member of the Champions’ board of directors since 2021.
FDA has initiated the approval of leucovorin calcium tablets, rushing them to market as part of a push from the Trump administration to identify potential treatments for autism spectrum disorder.
